GR3034400T3 - Use of piperazine derivatives for the treatment of cognitive disorders - Google Patents
Use of piperazine derivatives for the treatment of cognitive disordersInfo
- Publication number
- GR3034400T3 GR3034400T3 GR20000402090T GR20000402090T GR3034400T3 GR 3034400 T3 GR3034400 T3 GR 3034400T3 GR 20000402090 T GR20000402090 T GR 20000402090T GR 20000402090 T GR20000402090 T GR 20000402090T GR 3034400 T3 GR3034400 T3 GR 3034400T3
- Authority
- GR
- Greece
- Prior art keywords
- treatment
- cognitive disorders
- pct
- piperazine derivatives
- date
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929223153A GB9223153D0 (en) | 1992-11-05 | 1992-11-05 | Piperazine derivatives |
| PCT/GB1993/002197 WO1994009780A1 (en) | 1992-11-05 | 1993-10-25 | Use of piperazine derivatives for the treatment of cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3034400T3 true GR3034400T3 (en) | 2000-12-29 |
Family
ID=10724559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000402090T GR3034400T3 (en) | 1992-11-05 | 2000-09-13 | Use of piperazine derivatives for the treatment of cognitive disorders |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5827847A (OSRAM) |
| EP (1) | EP0877612B1 (OSRAM) |
| JP (1) | JP3238153B2 (OSRAM) |
| AT (1) | ATE195422T1 (OSRAM) |
| AU (1) | AU682155B2 (OSRAM) |
| CA (1) | CA2148593C (OSRAM) |
| DE (1) | DE69329252T2 (OSRAM) |
| DK (1) | DK0877612T3 (OSRAM) |
| ES (1) | ES2149216T3 (OSRAM) |
| GB (1) | GB9223153D0 (OSRAM) |
| GR (1) | GR3034400T3 (OSRAM) |
| HU (1) | HUT72049A (OSRAM) |
| LV (1) | LV12734B (OSRAM) |
| MX (1) | MX9306879A (OSRAM) |
| PT (1) | PT877612E (OSRAM) |
| TW (1) | TW252043B (OSRAM) |
| WO (1) | WO1994009780A1 (OSRAM) |
| ZA (1) | ZA937827B (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710481A1 (en) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Use of flesinoxan for cognition enhancement |
| US6271234B1 (en) * | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
| US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
| GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
| US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| ES2130116T3 (es) * | 1989-04-22 | 1999-07-01 | Wyeth John & Brother Ltd | Derivados de piperazina. |
| EP0955296A3 (en) * | 1989-04-22 | 2000-01-19 | American Home Products Corporation | Tertiary alkyl functionalized piperazine derivatives |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
| JP3049089B2 (ja) * | 1990-01-11 | 2000-06-05 | ファルマシア・アンド・アップジョン・カンパニー | 新規な中枢作用性の６，７，８，９―テトラヒドロ―３Ｈ―ベンズ［ｅ］インドールヘテロ環式化合物 |
| GB9022820D0 (en) * | 1990-10-19 | 1990-12-05 | Wyeth John & Brother Ltd | Piperazine derivatives |
| DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
| AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
-
1992
- 1992-11-05 GB GB929223153A patent/GB9223153D0/en active Pending
-
1993
- 1993-10-21 ZA ZA937827A patent/ZA937827B/xx unknown
- 1993-10-25 JP JP51081394A patent/JP3238153B2/ja not_active Expired - Fee Related
- 1993-10-25 PT PT93923615T patent/PT877612E/pt unknown
- 1993-10-25 EP EP93923615A patent/EP0877612B1/en not_active Expired - Lifetime
- 1993-10-25 DK DK93923615T patent/DK0877612T3/da active
- 1993-10-25 US US08/428,093 patent/US5827847A/en not_active Expired - Fee Related
- 1993-10-25 ES ES93923615T patent/ES2149216T3/es not_active Expired - Lifetime
- 1993-10-25 DE DE69329252T patent/DE69329252T2/de not_active Expired - Fee Related
- 1993-10-25 WO PCT/GB1993/002197 patent/WO1994009780A1/en not_active Ceased
- 1993-10-25 AT AT93923615T patent/ATE195422T1/de not_active IP Right Cessation
- 1993-10-25 CA CA002148593A patent/CA2148593C/en not_active Expired - Fee Related
- 1993-10-25 HU HU9501290A patent/HUT72049A/hu unknown
- 1993-10-25 AU AU53421/94A patent/AU682155B2/en not_active Ceased
- 1993-10-26 TW TW082108882A patent/TW252043B/zh active
- 1993-11-04 MX MX9306879A patent/MX9306879A/es not_active IP Right Cessation
-
2000
- 2000-09-13 GR GR20000402090T patent/GR3034400T3/el not_active IP Right Cessation
-
2001
- 2001-07-04 LV LVP-01-102A patent/LV12734B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2149216T3 (es) | 2000-11-01 |
| LV12734A (en) | 2001-10-20 |
| JP3238153B2 (ja) | 2001-12-10 |
| LV12734B (en) | 2002-01-20 |
| CA2148593C (en) | 2005-12-06 |
| HUT72049A (en) | 1996-03-28 |
| AU5342194A (en) | 1994-05-24 |
| DK0877612T3 (da) | 2000-10-09 |
| DE69329252D1 (de) | 2000-09-21 |
| JPH08502743A (ja) | 1996-03-26 |
| CA2148593A1 (en) | 1994-05-11 |
| EP0877612B1 (en) | 2000-08-16 |
| TW252043B (OSRAM) | 1995-07-21 |
| ATE195422T1 (de) | 2000-09-15 |
| PT877612E (pt) | 2000-11-30 |
| US5827847A (en) | 1998-10-27 |
| EP0877612A1 (en) | 1998-11-18 |
| DE69329252T2 (de) | 2001-03-29 |
| WO1994009780A1 (en) | 1994-05-11 |
| ZA937827B (en) | 1995-04-21 |
| GB9223153D0 (en) | 1992-12-16 |
| AU682155B2 (en) | 1997-09-25 |
| MX9306879A (es) | 1995-01-31 |
| HU9501290D0 (en) | 1995-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL123142A0 (en) | The use of adamantan-derivatives for the treatment of the inner ear | |
| BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| GB9300194D0 (en) | Piperazine derivatives | |
| GB9300195D0 (en) | Piperazine derivatives | |
| GB9206768D0 (en) | New compounds for use in the treatment of cancer | |
| AU5818394A (en) | Use of prodelphinidines for treating arthrosis | |
| GB9305672D0 (en) | Amide derivatives | |
| TW281673B (OSRAM) | ||
| GR3034400T3 (en) | Use of piperazine derivatives for the treatment of cognitive disorders | |
| AU3386299A (en) | N-aryloxyethylamine derivatives for the treatment of depression | |
| GB9304632D0 (en) | Amide derivatives | |
| DK0691846T3 (da) | Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet | |
| AU5696594A (en) | Triazoloquinazolines for the treatment of diseases of the central vervous system | |
| ES2103232A1 (es) | Nuevos compuestos derivados de 1h-imidazol-2-metanol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |